Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
1401 Apheresis Allogeneic Myelodysplasia Hematology 2025 Standard Therapy Germany 47
1402 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 58
1403 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 76
1404 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 55
1405 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 70
1406 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
1407 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 51
1408 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy United Kingdom 56
1409 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Italy 62
1410 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Norway 59
1411 Apheresis Allogeneic Myeloid Sarcoma Hematology 2025 Standard Therapy Ukraine 24
1412 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 63
1413 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 58
1414 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
1415 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 68
1416 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 71
1417 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 62
1418 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 5
1419 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Turkey 2
1420 Apheresis Allogeneic Hodgkin's Lymphoma (HL) Hematology 2025 Standard Therapy South Africa 38
1421 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Poland 60
1422 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 72
1423 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy USA 59
1424 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy NETHERLANDS 72
1425 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 74
1426 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 72
1427 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 19
1428 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 62
1429 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Switzerland 25
1430 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy USA 69
1431 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 64
1432 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Lithuania 55
1433 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Greece 42
1434 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy France 55
1435 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 49
1436 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 63
1437 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Portugal 68
1438 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 41
1439 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 64
1440 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 68
1441 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 61
1442 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 73
1443 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 39
1444 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 73
1445 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russian Federation 57
1446 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy BELARUS 22
1447 Apheresis Allogeneic Other Leukemia Hematology 2025 Standard Therapy Belgium 60
1448 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 48
1449 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 20
1450 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Lithuania 51
1451 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
1452 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Denmark 72
1453 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 56
1454 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 63
1455 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 68
1456 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 53
1457 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 70
1458 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 14
1459 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 57
1460 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 49
1461 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Russian Federation 43
1462 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 76
1463 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Belgium 63
1464 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 63
1465 Apheresis Allogeneic Other Leukemia, Specify, CNL Hematology 2025 Standard Therapy USA 70
1466 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 53
1467 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Iran 8
1468 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 21
1469 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Denmark 65
1470 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Romania 25
1471 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 27
1472 Apheresis Allogeneic Polycythaemia Vera Hematology 2025 Standard Therapy Germany 61
1473 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 25
1474 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 51
1475 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 70
1476 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 53
1477 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 61
1478 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russian Federation 49
1479 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 36
1480 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 62
1481 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 54
1482 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 74
1483 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 49
1484 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 62
1485 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 74
1486 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Argentine 57
1487 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 56
1488 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Belgium 71
1489 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Spain 59
1490 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2025 Standard Therapy USA 65
1491 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 14
1492 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Denmark 57
1493 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
1494 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 51
1495 Apheresis Allogeneic Richter Transformation CDLBCC Hematology 2025 Standard Therapy Germany 68
1496 Apheresis Allogeneic Acute Myelogenous Leukemia-MR Hematology 2025 Standard Therapy Russian Federation 16
1497 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
1498 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 66
1499 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 50
1500 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 38